Nick Wallace is an associate in Ropes & Gray’s health care group. Nick provides regulatory, investigative, and corporate governance advice to a wide range of clients, including health care providers, pharmaceutical and biotechnology companies, and colleges and universities.
Nick’s practice encompasses areas including conflict of interest, research, privacy, data and technology licensing, corporate governance, billing, fraud and abuse, and tax-exempt bond financing.
Nick’s work with pro bono clients includes representing immigration clients in asylum hearings and U Visa petitions and a veteran in a discharge status upgrade and disability benefits application.
- Investigating allegations with respect to intellectual property spin-off arrangements, research misconduct, and conflicts of interest.
- Representing provider in billing dispute responding to state Medicaid authorities’ demand for repayment.
- Drafting request for advisory opinion to the HHS Office of the Inspector General.
- Advising clients on privacy regulations, particularly questions concerning the EU General Data Protection Regulation and HIPAA.
- Advising clinical trial sponsors and research sites on informed consent matters, privacy regulations, and good clinical practice requirements.
- Representing health care company in federal False Claims Act qui tam action involving alleged breaches of Medicaid regulatory requirements.
- Advising boutique health care providers on challenges of applying reimbursement and privacy models to their businesses.
- Drafting operating agreements for hospital clients’ joint ventures.
- Representing universities and hospitals in tax-exempt and taxable bond issuances.
- Advising nonprofit boards on duties and sundry governance questions.
- Co-author, “What High Court's ACA Ruling Means For Health Insurers,” Law360 (May 7, 2020)
- Co-author, “Expanding Regulatory Oversight of Foreign Influence in NIH-Funded Research,” Bloomberg Law (July 23, 2019)
- Co-author, “GDPR Complicates Admissions Applications for U.S. Universities,” Bloomberg BNA’s Privacy Law Watch (June 27, 2018)
- Co-author, “Final Guidelines on Consent Requirements Under the EU General Data Protection Regulation: Implications for Scientific Research,” Bloomberg BNA’s Life Sciences Law & Industry Report (April 30, 2018)
- Co-author, “New Draft Guidelines on GDPR Consent Requirement’s Application to Scientific Research,” Bloomberg BNA’s Medical Law & Research Policy Report (January 17, 2018)
- Co-author, “Extraterritorial Effect of the GDPR and Implications for U.S. Academic Medical Centers Treating EU Patients,” Bloomberg BNA’s Medical Law & Research Policy Report (November 1, 2017)
- Co-author, “Laws and Ethics Affecting Clinical Trials in Africa,” Journal of Health Care Law and Policy (2017)
- Co-author, “Reconciling Personal Data Consent Practices in Clinical Trials with the EU General Data Protection Regulation,” Bloomberg BNA’s Medical Research Law & Policy Report (September 20, 2017)
- Co-author, “OIG’s Warranty Safe Harbor Opinion and Value-Based Care,” Law360 (September 14, 2017)
- “Tissue Repositories and Data Banks in the Era of the Revised Common Rule,” PRIM&R Social, Behavioral and Educational Research Conference (November 19-20, 2019)
- “Foreign Influence in Research: Foreign Research Support, ‘Foreign Components,’ and Personal Income from Foreign Entities,” PRIM&R Social, Behavioral and Educational Research Conference (November 18, 2019)
- “European Union, Japan, and U.S. Privacy Law: Implications for Data Sharing,” 16th DIA Japan Annual Meeting, Tokyo, Japan (November 11, 2019)
- “Risk Based Approaches to Handle and Protect Clinical Trial Data,” Q1 Life Science Data Privacy Governance & GDPR Alignment Conference, Philadelphia (July 27, 2018)
- “The EU General Data Protection Regulation: Implications for Research,” ADVARRA Webinar (June 13, 2018)
- “EU General Data Protection Regulation: What U.S. Research Institutions Need to Know,” Public Responsibility in Medicine and Research (PRIM&R) Webinar (April 25, 2018)
- JD, Yale Law School, 2015; editor,Yale Journal on Regulation
- BA, with highest distinction, Phi Beta Kappa, Indiana University, 2011
Admissions / Qualifications
- California, 2015